Why Do Drugs Work in CLL?
- 1 January 1996
- journal article
- review article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 22 (sup2) , 1-11
- https://doi.org/10.3109/10428199609102699
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Fludarabine- and gemcitabine-induced apoptosis: incorporation of analogs into DNA is a critical eventCancer Chemotherapy and Pharmacology, 1995
- Original article: Fludarabine – present status and future developments in chronic lymphocytic leukemia and lymphomaAnnals of Oncology, 1994
- Clinical Experience with Fludarabine in LeukaemiaDrugs, 1994
- Mechanisms of resistance to chlorambucil in chronic lymphocytic leukemiaLeukemia Research, 1991
- Fludarabine: a new agent with major activity against chronic lymphocytic leukemiaBlood, 1989
- Amplification and increased expression of alpha class glutathione S-transferase-encoding genes associated with resistance to nitrogen mustards.Proceedings of the National Academy of Sciences, 1988
- Metabolism and reactions of alkylating agentsPharmacology & Therapeutics, 1987
- Glutathione-conferred resistance to antineoplastics: Approaches toward its reductionCancer Treatment Reviews, 1984
- The interaction of bifunctional alkylating agents with the DNA of tumour cellsPublished by Elsevier ,1976
- The selectivity of action of alkylating agents and drug resistance—IIIBiochemical Pharmacology, 1970